NI
PTCT icon

Numeric Investors’s PTC Therapeutics PTCT Stock Holding History

Numeric Investors’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-470,982
Closed -$9.42M – 1148
2017
Q3 		$9.42M Buy
+470,982
New +$9.22M 0.07% 266
2017
Q2 		– Sell
-616,004
Closed -$6.06M – 1130
2017
Q1 		$6.06M Buy
616,004
+47,685
+8% +$577K 0.06% 296
2016
Q4 		$6.2M Buy
+568,319
New +$5.96M 0.06% 290
2016
Q3 		– Sell
-126,400
Closed -$887K – 1167
2016
Q2 		$887K Buy
+126,400
New +$927K 0.01% 613
2016
Q1 		– Sell
-12,600
Closed -$408K – 1104
2015
Q4 		$408K Buy
12,600
+1,200
+11% +$35.3K ﹤0.01% 783
2015
Q3 		$304K Sell
11,400
-3,400
-23% -$145K ﹤0.01% 838
2015
Q2 		$712K Buy
14,800
+8,900
+151% +$519K 0.01% 591
2015
Q1 		$359K Buy
+5,900
New +$360K ﹤0.01% 700
2014
Q3 		– Sell
-259,593
Closed -$6.79M – 917
2014
Q2 		$6.79M Buy
259,593
+8,311
+3% +$178K 0.1% 195
2014
Q1 		$6.57M Buy
+251,282
New +$6.75M 0.11% 192

Other funds holding PTCT

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Numeric Investors's PTCT Position: Q4 2017 in Review

Numeric Investors sold out of PTC Therapeutics (PTCT) in Q4 2017, closing a stake of 470,982 shares — an estimated $9.42M sold.

Numeric Investors first reported a position in PTCT in Q1 2014 and held it in 10 quarters. The position peaked at $9.42M in Q3 2017. 125 funds tracked by Wall St. Rank hold PTCT as of Q4 2017.

  • Numeric Investors reported no remaining PTC Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Numeric Investors sold 470,982 PTC Therapeutics shares in Q4 2017, an estimated $9.42M.
  • Numeric Investors first reported a position in PTC Therapeutics in Q1 2014 and held it in 10 quarters.
  • Numeric Investors's PTC Therapeutics position peaked at $9.42M in Q3 2017.
  • 125 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.